Search Results for "Equine Leukemia Prognosis"

02:13 EDT 3rd July 2015 | BioPortfolio

Matching Channels

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Chronic Lymphocytic Leukemia CLL

Chronic lymphocytic leukemia is a disease in which mature lymphocytes become cancerous and gradually replace normal cells in lymph nodes. CLL mainly affects elderly males in North America and Europe...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

St. Jude researchers note that chromosomal rearrangement may be the key to progress against aggressive infant leukemia

St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project study highlights need for targeted therapies against a rare infant leukemia with a poor prognosis.

Western Equine Encephalitis - Pipeline Review, H1 2015

Western Equine Encephalitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Western Equine Encephalitis - Pipeline Review, H1 2015’, provides an overview of the Western Equine Encep...

Paucity of Somatic Mutations in Aggressive Childhood Leukemia

In-depth DNA sequencing and RNA expression analysis shows that a particularly aggressive form of infant and childhood leukemia--mixed-lineage leukemia-rearranged gene (MLL-R) acute lymphoblastic leuke...

FDA Approves Blinatumomab for Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

On December 3, 2014, the U. S. Food and Drug Administration granted accelerated approval for BLINCYTOTM (blinatumomab) for the treatment of Philadelphia chromosome-negative relapsed or refractory B-ce...

Agent Shows Impressive Results in Poor-Prognosis ALL

In patients with refractory/relapsed acute lymphoblastic leukemia (ALL), remission is greater with inotuzumab ozogamicin than with standard-of-care chemotherapy, phase 3 results show. Medscape Medic...

Vical, AnGes partner for equine polyclonal antibody therapy against Ebola

US-based Vical and Japanese biopharmaceutical company AnGes MG have partnered to develop and commercialize an equine polyclonal antibody therapy for patients with Ebola virus disease.

Researchers effectively, safely overcome radiation resistance in leukemia with an engineered precision medicine

Improved survival rates have been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to a new study.

DNMT3A Mutation Related to Poor-Risk AML

Patients with acute myeloid leukemia who had a DNMT3A mutation had poorer disease prognosis, according to an analysis of patients aged 60 years or younger.

Matching PubMed Articles

Clinical treatment and prognosis of equine odontoclastic tooth resorption and hypercementosis.

Equine odontoclastic tooth resorption and hypercementosis is an infrequent and under-diagnosed form of severe dental disease in horses that can affect quality of life. The study was performed to compa...

DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.

Equine Influenza Virus.

For decades the horse has been viewed as an isolated or "dead-end" host for influenza A viruses, with equine influenza virus being considered as relatively stable genetically. Although equine influenz...

Socio-economic disparities in survival from childhood leukemia in the U.S.A. and globally: a meta-analysis.

Despite advancements in the treatment of childhood leukemia, socioeconomic status (SES) may potentially affect disease prognosis. This study aims to evaluate whether SES is associated with survival fr...

Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols.

In recent decades, the prognosis for childhood leukemia has improved, especially for acute lymphoblastic leukemia (ALL). In Thailand, though, the survival rate for ALL is unimpressive. In 2006, standa...

Search Whole site using Google


Advertisement Advertisement